Pharmacokinetics of Oral Methotrexate in Children

Cancer Research

Volumn 43, Issue 5, 1983, Pages 2342-2345

  Balis, Frank M ^a   Savitch, Jill L ^a   Bleyer, W Archie ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b The Leukemia & Lymphoma Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYMETHOTREXATE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG THERAPY; DRUG URINE LEVEL; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; THERAPY;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; HUMAN; KINETICS; LEUKEMIA, LYMPHOCYTIC; MALE; METABOLIC CLEARANCE RATE; METHOTREXATE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0020611303     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Aherne, G. W., and Quinton, M. Techniques for the measurement of methotrexate in biological samples. Cancer Treat. Rep. (Suppl. 1), 65: 55–60,1981.
2. Balls, F. M., and Bleyer, W. A. Variability in serum rnethotrexate after oral administration. Proc. Am. Assoc. Cancer Res. (Suppl. 1), 22:174,1981.
3. Benn, A., Swan, C. H. J., Cooke, W. T., Blair, J. A., Matty, A. J., and Smith, M. E. Effect of intraluminal pH on the absorption of pteroylmonoglutamic acid. Br. Med. J., 1: 148–150,1971.
4. Bleyer, W. A. Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat. Rev., 4: 87–101, 1977.
5. Craft, A. W., Rankin, A., and Aherne, W. Methotrexate absorption in children with acute lymphoblastic leukemia. Cancer Treat. Rep. (Suppl. 1), 65: 77–81, 1981.
6. Falk, L. C., Clark, D. R., Kalman, S. M., and Long, T. F. Enzymatic assay for methotrexate in serum and cerebrospinal fluid. Clin. Chem., 22: 785–788, 1976.
7. Flores, O. R., Sun, L., Vaziri, N. D., and Miyada, D. S. Colorimetric rate method for the determination of creatinine as implemented by the Beckman Creatinine Analyzer 2. Am. J. Med. Technol., 46: 792–798,1980.
8. Freeman-Narrod, M. The pharmacology of methotrexate. In: R. Porter and E. Wiltshaw (eds.), Methotrexate in the Treatment of Cancer, pp. 17–21. Baltimore, Md.: The Williams & Wilkins Co., 1962.
9. Gibaldi, M., and Perrier, D. Pharmacokinetics, pp. 293–296. New York: Marcel Dekker, Inc., 1975.
10. Henderson, E. S., Adamson, R. H., and Oliverio, V. T. The metabolic fate of tritiated methotrexate II. Absorption and excretion in man. Cancer Res., 25: 1018–1024, 1965.
11. Kearney, P. J., Light, P. A., Preece, A., and Mott, M. G. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother. Pharmacol., 3: 117–120,1979.
12. Pinkerton, C. R., Welshman, S. G., Dempsey, S. I., Bridges, J. M., and Glasgow, J. F. T. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukemia. Br. J. Cancer, 42: 613–615, 1980.
13. Strum, W. B. pH-Dependent carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum. J. Pharmacol. Exp. Ther., 203: 640–645, 1977.
14. Wan, S. H., Huffman, D. H., Azamoff, D. L., Stephens, R., and Hoogstraten, B. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res., 34: 3487–3491,1974.